Contact UsCompany ProfileHome
Saaskin Technologies
Send Inquiry Send SMS
Snibe MAGLUMI SCCA (CLIA) Snibe MAGLUMI SCCA (CLIA) Snibe MAGLUMI SCCA (CLIA)
Snibe MAGLUMI SCCA (CLIA)
Snibe MAGLUMI SCCA (CLIA) Snibe MAGLUMI SCCA (CLIA)

Snibe MAGLUMI SCCA (CLIA)

Product Details:

  • Accuracy High (per analyzer calibration)
  • Shelf Life 12 Months
  • Storage Instructions 2-8C; Protect from light
  • Instruments Type Clinical Chemistry Immunoassay System
  • Features High sensitivity; specificity; compatible with MAGLUMI analyzers
  • Function Detection of SCCA biomarker
  • Usage Type Diagnostic/Reagent
  • Click to View more
X

Snibe MAGLUMI SCCA (CLIA) Price And Quantity

Snibe MAGLUMI SCCA (CLIA) Product Specifications

  • 12 Months
  • 2-8C; Protect from light
  • Yes
  • High (per analyzer calibration)
  • Detection of SCCA biomarker
  • Transparent/Liquid
  • High sensitivity; specificity; compatible with MAGLUMI analyzers
  • Clinical Chemistry Immunoassay System
  • 0.1150 ng/mL
  • Chemiluminescence Immunoassay (CLIA)
  • Diagnostic/Reagent
  • No
  • Immunochemistry Analyzer Reagent (SCCA Assay)
  • New
  • No (used with MAGLUMI system)
  • Not Applicable (used with analyzer system)
  • Automated
  • Quantitative determination of Squamous Cell Carcinoma Antigen (SCCA) in human serum or plasma
  • Liquid Reagent (for clinical analysis)
  • Approx. 30 minutes
  • Two-step immunoassay with chemiluminescent detection
  • Reagent, calibrator supplied by Snibe
  • MAGLUMI Series Immunoassay Analyzer
  • Detection and monitoring of squamous cell carcinoma in oncology
  • Recommended per analyzer protocol
  • Human serum or plasma

Product Description

Brand Snibe
Sample Type Serum
Cancer Marker 100T
CAT No. 130201018M
Application Cancer Marker

The kit has been designed for the quantitative determination of
Squamous Cell Carcinoma Antigen (SCCA) in human serum.
The method can be used for samples over the range of
0.13-100.0ng/ml. The test has to be performed on the Fully-auto
chemiluminescence immunoassay (CLIA) analyzer MAGLUMI
(Including Maglumi 600,Maglumi 1000,Maglumi 1000 Plus,
Maglumi 2000,Maglumi 2000 Plus,Maglumi 3000 and Maglumi
4000).



Advanced Oncology Biomarker Detection

The Snibe MAGLUMI SCCA (CLIA) kit offers high sensitivity and specificity for squamous cell carcinoma antigen detection in serum or plasma. Its advanced chemiluminescence technology ensures precise quantification, supporting clinicians in both initial diagnosis and ongoing patient monitoring. The automated process integrated into MAGLUMI analyzers enhances workflow efficiency in clinical laboratories.


Seamless Integration with MAGLUMI Analyzers

Specially designed for use with MAGLUMI Series Immunoassay Analyzers, this reagent kit enables streamlined, automated operation. Laboratories benefit from reduced manual intervention, real-time result delivery, and a user-friendly interface, ensuring consistent and accurate oncology testing outcomes.


Reliable Performance and Convenient Storage

With a 12-month shelf life and easy storage conditions (2-8C, protected from light), the Snibe SCCA assay maintains high stability. Laboratories can confidently manage inventory and planning, knowing the reagents are ready-to-use and deliver reliable data throughout their offering period.

FAQ's of Snibe MAGLUMI SCCA (CLIA):


Q: How does the Snibe MAGLUMI SCCA (CLIA) kit detect squamous cell carcinoma antigen?

A: The kit employs a two-step chemiluminescent immunoassay (CLIA) principle, enabling highly sensitive and specific detection of SCCA in human serum or plasma using automated MAGLUMI analyzers.

Q: What types of samples are compatible with this assay?

A: This assay is validated for use with human serum or plasma specimens, supporting versatile application in clinical settings for oncology diagnostics.

Q: When should the SCCA test be performed using this kit?

A: The test is suitable for both the initial detection and ongoing monitoring of squamous cell carcinoma in patients, as recommended by a healthcare professional.

Q: Where can the Snibe MAGLUMI SCCA kit be used?

A: It is intended for clinical laboratories equipped with the MAGLUMI Series Immunoassay Analyzers, making it ideal for hospital and reference lab oncology departments.

Q: What is the testing process for SCCA with this reagent kit?

A: Simply load the liquid reagents and calibrators into the compatible MAGLUMI analyzer, add patient samples, and initiate the fully automated analysis; results are typically available in about 30 minutes.

Q: What are the primary benefits of using the Snibe SCCA assay?

A: The assay provides high accuracy, sensitivity, and specificity in the quantification of SCCA, supporting clinicians with reliable data for diagnosis and patient management. Automation minimizes error and streamlines testing.

Q: What are the recommended storage conditions for this product?

A: Store the kit at 2-8C and protect it from light to maintain reagent integrity throughout its 12-month shelf life.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Medical CLIA' category



trade india member
SAASKIN CORPORATION PRIVATE LIMITED All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.